2020
DOI: 10.4253/wjge.v12.i6.172
|View full text |Cite
|
Sign up to set email alerts
|

Management of antiplatelet or anticoagulant therapy in endoscopy: A review of literature

Abstract: Endoscopic procedures hold a basal risk of bleeding that depends on the type of procedure and patients’ comorbidities. Moreover, they are often performed in patients taking antiplatelet and anticoagulants agents, increasing the potential risk of intraprocedural and delayed bleeding. Even if the interruption of antithrombotic therapies is undoubtful effective in reducing the risk of bleeding, the thromboembolic risk that follows their suspension should not be underestimated. Therefore, it is fundamental for eac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 124 publications
(146 reference statements)
0
1
0
Order By: Relevance
“…First, instructions on diet and bowel preparation must be provided in written form, the solution for preparation must be chosen among those recommended by the guidelines, performed in a split fashion, and colonoscopy must performed within 5 hours following bowel preparation [48][49]. Furthermore, at the preliminary colonoscopy interview, the concomitant therapy must be investigated, and the possible intake of antiplatelet and/or anticoagulant drugs managed preventively in accordance with the guidelines [50].…”
Section: Accepted Manuscriptmentioning
confidence: 99%
“…First, instructions on diet and bowel preparation must be provided in written form, the solution for preparation must be chosen among those recommended by the guidelines, performed in a split fashion, and colonoscopy must performed within 5 hours following bowel preparation [48][49]. Furthermore, at the preliminary colonoscopy interview, the concomitant therapy must be investigated, and the possible intake of antiplatelet and/or anticoagulant drugs managed preventively in accordance with the guidelines [50].…”
Section: Accepted Manuscriptmentioning
confidence: 99%